0001209191-20-064582.txt : 20201218 0001209191-20-064582.hdr.sgml : 20201218 20201218210839 ACCESSION NUMBER: 0001209191-20-064582 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201217 FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nash Huw M. CENTRAL INDEX KEY: 0001780085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38938 FILM NUMBER: 201402164 MAIL ADDRESS: STREET 1: C/O STOKE THERAPEUTICS, INC. STREET 2: 45 WIGGINS AVE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Stoke Therapeutics, Inc. CENTRAL INDEX KEY: 0001623526 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471144582 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 PRESTON COURT CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-430-8200 MAIL ADDRESS: STREET 1: 3 PRESTON COURT CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ASOthera Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141028 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-17 0 0001623526 Stoke Therapeutics, Inc. STOK 0001780085 Nash Huw M. C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730 0 1 0 0 COO & CBO Common Stock 2020-12-17 4 M 0 41985 0.60 A 41985 D Common Stock 2020-12-17 4 S 0 41985 60.00 D 0 D Common Stock 2020-12-18 4 M 0 8015 0.60 A 8015 D Common Stock 2020-12-18 4 S 0 8015 60.00 D 0 D Employee Stock Option (Right to Buy) 0.60 2020-12-17 4 M 0 41985 0.00 D 2028-04-02 Common Stock 41985 180386 D Employee Stock Option (Right to Buy) 0.60 2020-12-18 4 M 0 8015 0.00 D 2028-04-02 Common Stock 8015 172371 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The option vested as to 1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date. /s/ Stephen Tulipano, Attorney-in-Fact 2020-12-18